Conditions for Which There is a Documented Medical Necessity to Receive Treatment With Rotigotine

0
Pipeline Programs
1
Companies
1
Clinical Trials
0
Approved Products

Pipeline by Development Stage

Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
0
0
0
0
Early DiscoveryClinical DevelopmentMarket

Competitive Landscape

1 companies ranked by most advanced pipeline stage

UP
UCB PharmaBelgium - Brussels
1 program
Rotigotine patchN/A1 trial
Active Trials
NCT01095484Completed520Est. Dec 2012

Trial Timeline

Clinical trial activity over time

2021
2022
2023
2024
2025
2026
UCB PharmaRotigotine patch

Clinical Trials (1)

Total enrollment: 520 patients across 1 trials

NCT01095484UCB PharmaRotigotine patch

Named Patient Program With Rotigotine Transdermal System

Start: Nov 2008Est. completion: Dec 2012520 patients
N/ACompleted

Phase Legend

Preclinical— Lab & animal studies
Phase 1— Safety & dosing
Phase 2— Efficacy testing
Phase 3— Large-scale trials
On Market— Approved & available

Key Insights

1 companies competing in this space